Clinical Pharmacokinetics Pharmacy Handbook 2nd Edition

HealthPharmacy
Last updated on
Avatar photo
By Bryan Tan Van Hong

Publicity Associate at YPC. Currently working in Esyms, an online pharmacy platform and Registered Pharmacist at a retail pharmacy. Oh, and not to forget, pun enthusiast.

This Clinical Pharmacokinetics Pharmacy Handbook 2nd Edition contains the updated information and practice in Clinical Pharmacokinetics Pharmacy. Examples of real case scenario are included in each of the chapter for a better understanding in calculation concept and application.

The handbook can be downloaded here.

Related

Starting from 1 January 2019, all applications for pharmacy licenses and permits will be associated with a newly imposed fee. The amendments are as follow: “I) Di bawah Peraturan 28 Peraturan-Peraturan Racun (Pindaan) 2018 iaitu :  28. (1) An Application for a licence under the Act shall be accompanied by the following fees:    …

Replaceable, or Irreplaceable?

Last updated on

Written by Bryan Tan – Marketing and Communications Associate at YPC, currently a PRP at a retail pharmacy, and pun enthusiast   The director of the National Pharmaceutical Regulatory Agency (NPRA) Datin Dr Faridah Aryani Md Yusof stated that amidst the impending Industrial Revolution 4.0, pharmacists roles will not be replaced by technology. It is…

At the Malaysian Society of Hypertension’s (MSH) 15th Annual Scientific Meeting, Professor Abdul Rashid Abdul Rahman, the Chairman Working Group on 5th Malaysian Hypertension Clinical Practice Guidelines (CPG) 2018 said that many updates can be expected from the new CPG. One of these new recommendations is the preference for validated electronic blood pressure (BP) sets over mercury sphygmomanometers....

In light of COVID-19 and the resultant rapid expansion of pharmacists’ roles, Malaysian Pharmaceutical Society has released a guideline for Malaysian pharmacists. COVID-19 Pandemic Guidance Document for Malaysian Pharmacists Version 1 (March 2020) outlines 3 main points that pharmacists can take to ensure optimum participation in the crisis together with other healthcare professionals. The main…

Since our last article on COVID-19, so much has changed-the number of reported cases, better understanding of the virus’ characteristics, and its rebranding to COVID-19. After a harrowing month into the new decade, there’s finally some good news in 2020! This article will cover the rationale behind rebranding, latest statistics, and the roles of pharmacists…

Thinking Outside the KOTAK

Last updated on

Written by Bryan Tan – Marketing and Communications Associate at YPC, currently a PRP at a retail pharmacy, and pun enthusiast   Established in 2016, the Oral Health Program – Kesihatan Oral Tanpa Asap Rokok (KOTAK) is a prominent initiative by the Ministry of Health Malaysia and the Ministry of Education Malaysia which aims to…

Others

Coronavirus Declared as Global Emergency by WHO

Last updated on

The recent coronavirus outbreak took us by surprise. This storm came as sudden as a midnight deluge, and it seems like it is here to stay. Admittedly, even I myself am wearing a mask as I type this. What seem to otherwise be commonplace items such as face masks and hand sanitizers are now scarce…

  It has been a somber Chinese New Year - no, not just because of less ang paus - but because of the novel coronavirus that still continues to propagate across the entire globe. Having been declared a global health emergency, the virus has infected over 20 thousand people and proven fatal to 427.  Today,...

WHO to look into drug pricing?

Last updated on

Our health ministry has urged the World Health Organisation (WHO) to look into drug pricing by major drug companies. This came about amidst the pressure on the ministry to utilise Compulsory Licensing (CL)* to gain access to generic versions of a Hepatitis C medication. “I hope the international community could look at how pharmaceutical companies…

Remdesivir in Malaysia As everyone eagerly awaits results from clinical trials regarding treatment and vaccination option(s) for COVID-19, a possible “knight in shining armour” emerges: Remdesivir. Remde-saviour? Currently, the medication is undergoing 6 separate clinical trials for COVID-19: 2 initiated by Gilead (the manufacturer) (moderate & severe manifestations) 2 by health authorities in China (mild/moderate...

This is an update on the ongoing case regarding the abolishment of BIPK. To understand the background of the story, be sure to have a read at it here.   Ever since the announcement of the abolishment of the critical allowance, the government has been subjected to endless public furore. Many stakeholders have since voiced…

Poison Found in Cosmetic Product

Last updated on

Written by Bryan Tan – Marketing and Communications Associate at YPC, currently a PRP at a retail pharmacy, and pun enthusiast   This is not an april fool’s joke! The Desk of the Director General of Health released a statement on 1 April on 2 cosmetic products found to contain a scheduled poison. The 2…